Pascal Biosciences

Biotechnology
Founded in 2011-01-01
Seattle, Washington, United States
http://www.pascalbiosciences.com/
For Profit

About Pascal Biosciences

Pascal Biosciences Inc. (PAS, formerly, bioMmune Technologies Inc.) is a biotechnology company engaged in developing breakthrough treatments in the field of immuno-oncology. Their strategy aims to leverage their innovative technologies and experienced leadership and scientific team to develop new, effective therapeutics that will change the lives of patients. Pascal is headquartered in Vancouver, Canada. The company trades on the TSX Venture Exchange under the symbol “PAS”.

Company Metrics

  • Employees: 51-100
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 343750 USD
  • Last Funding: 343750 USD (Grant)
  • Funding Status: IPO

Technology Stack

Pascal Biosciences actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology

Headquarters: Seattle, Washington, United States